Aldeyra Therapeutics, Inc.

NASDAQ:ALDX

Biotechnology

Healthcare
$0.90 +3.01%

+$0.06 today

Market cap
$54.28M
Beta
1.19
P/E (TTM)
-4.2
EPS (TTM)
-$0.45
52W Low $1.07High $6.18

Volume 1.45M

Average 2.13M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$35.27M

FY 2025 · Annual

Net Income

-$33.85M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development44.94M47.31M29.46M48.22M25.66M
Selling, General & Admin11.28M15.37M13.34M11.89M9.6M
Operating Expenses56.22M62.68M42.79M60.12M35.27M
Depreciation & Amortization264.18K258.71K262.78K249.62K251.99K
EBITDA(55.77M)(60.07M)(35.21M)(53.68M)(31.69M)
EBITDA Margin—————
Operating Income(56.22M)(62.68M)(42.79M)(60.12M)(35.27M)
Operating Margin—————
Interest Income185.36K2.35M7.32M6.19M3.32M
Interest Expense1.74M1.69M2.07M1.93M1.91M
Other Income / Expenses(1.56M)655.35K5.25M4.27M1.42M
Income Before Tax(57.78M)(62.02M)(37.54M)(55.85M)(33.85M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(57.78M)(62.02M)(37.54M)(55.85M)(33.85M)
Net Margin—————
EPS (Basic)(1.07)(1.06)(0.64)(0.94)(0.56)
EPS (Diluted)(1.07)(1.06)(0.64)(0.94)(0.56)
Weighted Avg Shares54.04M58.41M58.94M59.48M60.06M
Weighted Avg Shares (Diluted)54.04M58.41M58.94M59.48M60.06M

ALDX Earnings Waterfall · TTM

NASDAQ:ALDX · Revenue to Net Income

Key Ratios

EPS$-0.46
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-8.9
P/S Ratio0.0

Analysis

$0 of revenue converted into -$27.4M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-0.46, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingAug 12, 2026
10-QQuarterly reportAug 6, 2026
8-KCurrent reportJul 30, 2026
SC 13G/ASC 13G/A filingJul 27, 2026
8-KCurrent reportJul 15, 2026

How much revenue does ALDX generate?

Aldeyra Therapeutics, Inc. (ALDX) reported $0.00 of revenue in fiscal 2025.

Is ALDX profitable?

Aldeyra Therapeutics, Inc. (ALDX) reported -$33.85M of net income.